Vedolizumab T9914
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Vedolizumab is a humanized monoclonal antibody that targets the _4_7 integrin for the treatment of ulcerative colitis and Crohn's disease.
CAS nr:
943609-66-3
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Cytoskeletal Signaling
Target:
Integrin
